Siesling S, van Vugt J P, Zwinderman K A, Kieburtz K, Roos R A
Department of Neurology, Leiden University Medical Centre, The Netherlands.
Mov Disord. 1998 Nov;13(6):915-9. doi: 10.1002/mds.870130609.
An objective assessment of the clinical findings in patients with Huntington's disease (HD) is necessary for an evaluation of the longitudinal progression of the disease features. The Unified Huntington's Disease Rating Scale (UHDRS) is a scale to assess clinical performance and functional capacity. The authors examined the 1-year change in UHDRS scores in 78 patients with HD examined either in Leiden, the Netherlands (24 men, 25 women), or in Rochester, New York, United States (12 men, 17 women). A significant decline was seen in motor function, measured with the total motor scale. The total dystonia score increased significantly; the total chorea score did not. The frequency of behavioral disorders tended to increase. The scores on independence scale, functional assessment, total functional capacity, and symbol digit decreased significantly. No relation was observed between the UHDRS items and the age at onset or duration of illness. Thirteen patients with 2-year follow up showed a clear increase in score on the total motor scale and a decline on the independence scale and in total functional capacity. The UHDRS may also be used as a tool for determining therapeutic intervention. Annual evaluation of the total motor scale in every patient gives a clear description of the motor progression of the disease. The authors suggest performing a total UHDRS evaluation every second year for every HD patient as part of the routine longitudinal evaluation.
对亨廷顿舞蹈症(HD)患者的临床发现进行客观评估,对于评估疾病特征的纵向进展是必要的。统一亨廷顿舞蹈症评定量表(UHDRS)是一种用于评估临床表现和功能能力的量表。作者检查了78例HD患者的UHDRS评分在1年中的变化,这些患者分别来自荷兰莱顿(24名男性,25名女性)或美国纽约罗切斯特(12名男性,17名女性)。用总运动量表测量发现运动功能有显著下降。肌张力障碍总分显著增加;舞蹈症总分未增加。行为障碍的频率有增加趋势。独立量表、功能评估、总功能能力和符号数字测验的得分显著下降。未观察到UHDRS各项与发病年龄或病程之间的关联。13例接受2年随访的患者显示,总运动量表得分明显增加,独立量表得分和总功能能力下降。UHDRS也可作为确定治疗干预的工具。每年对每位患者的总运动量表进行评估,可清晰描述疾病的运动进展情况。作者建议,作为常规纵向评估的一部分,每隔一年对每位HD患者进行一次完整的UHDRS评估。